Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression

Figure S.6 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression

<p>Figure S.6</p>

Αποθηκεύτηκε σε:

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριος συγγραφέας:	Xufeng Lu (14960724) (author)
Άλλοι συγγραφείς:	Dazhuan E. Xin (14960727) (author), Juanjuan K. Du (14960730) (author), Quanli C. Zou (14960733) (author), Qian Wu (14960736) (author), Yanan S. Zhang (14960739) (author), Wenhai Deng (14960742) (author), Jicheng Yue (14960745) (author), Xing S. Fan (14960748) (author), Yuanyuan Zeng (9330065) (author), Xiaju Cheng (14960751) (author), Xue Li (14960754) (author), Zhaoyuan Hou (14960757) (author), Man Mohan (14960760) (author), Ting C. Zhao (14960763) (author), Xiaomei Lu (14960766) (author), Zhijie Chang (14960769) (author), Liyan Xu (14960772) (author), Yu Sun (14960775) (author), Xiongbing Zu (14960778) (author), Yu Zhang (14960781) (author), Y. Eugene Chinn (14960784) (author)
Έκδοση:	2025
Θέματα:	Cancer Cancer Biology Immuno-oncology Gynecological Cancers Uterine cancer Immunotherapy Combination immunotherapy Oncogenes & Tumor Suppressors Tumor suppressor genes
Ετικέτες:	Προσθήκη ετικέτας Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!

Παρόμοια τεκμήρια

Figure S.1 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Figure S.2 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Figure S.3 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Figure S.4 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Figure S.5 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Figure S.7 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Figure S.8 from Loss of LOXL2 Promotes Uterine Hypertrophy and Tumor Progression by Enhancing H3K36ac-Dependent Gene Expression
ανά: Xufeng Lu (14960724)
Έκδοση: (2025)

Supplementary figures and tables FTS1 from Intraperitoneal Monocytes plus IFNs as a Novel Cellular Immunotherapy for Ovarian Cancer: Mechanistic Characterization and Results from a Phase I Clinical Trial
ανά: Daniel S. Green (15047598)
Έκδοση: (2025)

Supplementary Figure 1 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
ανά: Francisco Exposito (16721403)
Έκδοση: (2025)

Supplementary Figure 2 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
ανά: Francisco Exposito (16721403)
Έκδοση: (2025)

Supplementary Figure 3 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
ανά: Francisco Exposito (16721403)
Έκδοση: (2025)

Supplementary Figure 4 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
ανά: Francisco Exposito (16721403)
Έκδοση: (2025)

Supplementary Figure 5 from PTEN Loss Confers Resistance to Anti–PD-1 Therapy in Non–Small Cell Lung Cancer by Increasing Tumor Infiltration of Regulatory T Cells
ανά: Francisco Exposito (16721403)
Έκδοση: (2025)

Supplementary Tables from MYC Overexpression Drives Immune Evasion in Hepatocellular Carcinoma That Is Reversible through Restoration of Proinflammatory Macrophages
ανά: Renumathy Dhanasekaran (14962092)
Έκδοση: (2025)

Figure S1 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S2 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S3 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S4 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S5 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S6 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Figure S7 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Table S1-S9 from BRCA1 Insufficiency Induces a Hypersialylated Acidic Tumor Microenvironment That Promotes Metastasis and Immunotherapy Resistance
ανά: Xiaodong Shu (16721586)
Έκδοση: (2025)

Supplementary Tables from Biallelic <i>Dicer1</i> Mutations in the Gynecologic Tract of Mice Drive Lineage-Specific Development of <i>DICER1</i> Syndrome–Associated Cancer
ανά: Yemin Wang (17315078)
Έκδοση: (2025)

Supplementary Data from PP2Ac Deficiency Enhances Tumor Immunogenicity by Activating STING–Type I Interferon Signaling in Glioblastoma
ανά: Isha Mondal (16721699)
Έκδοση: (2025)

Figure 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
ανά: Robert L. Hollis (15034814)
Έκδοση: (2025)

Figure 2 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
ανά: Robert L. Hollis (15034814)
Έκδοση: (2025)

Figure 3 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
ανά: Robert L. Hollis (15034814)
Έκδοση: (2025)

Figure 4 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
ανά: Robert L. Hollis (15034814)
Έκδοση: (2025)

Figure 5 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
ανά: Robert L. Hollis (15034814)
Έκδοση: (2025)

Table 1 from Multiomic Characterization of High-Grade Serous Ovarian Carcinoma Enables High-Resolution Patient Stratification
ανά: Robert L. Hollis (15034814)
Έκδοση: (2025)

Supplementary Table S1-19 from Germline Cancer Gene Expression Quantitative Trait Loci Are Associated with Local and Global Tumor Mutations
ανά: Yuxi Liu (15293121)
Έκδοση: (2025)

Table S2 from MEX3A Mediates p53 Degradation to Suppress Ferroptosis and Facilitate Ovarian Cancer Tumorigenesis
ανά: Cheng-Kai Wang (14963880)
Έκδοση: (2025)

Supplementary Data from Attenuation of Sialylation Augments Antitumor Immunity and Improves Response to Immunotherapy in Ovarian Cancer
ανά: Kankan Cao (16437263)
Έκδοση: (2025)

Data Sheet 1_Intra-voxel incoherent motion biomarker repeatability in healthy volunteers and sensitivity to chemoradiotherapy-induced changes in patients with uterine cervical cancer.pdf
ανά: Damien J. McHugh (22686269)
Έκδοση: (2025)

Table S1 from HDACi-dependent Microenvironmental Normalization Overcomes Tumor Burden–induced T-cell Exhaustion
ανά: Andrew Nguyen (17142197)
Έκδοση: (2025)

Supplemental Figure 1 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
ανά: Amir T. Fathi (15313195)
Έκδοση: (2025)

Supplemental Figure 2 from Multicenter Phase I Trial of Ivosidenib as Maintenance Treatment Following Allogeneic Hematopoietic Cell Transplantation for <i>IDH1</i>-Mutated Acute Myeloid Leukemia
ανά: Amir T. Fathi (15313195)
Έκδοση: (2025)

Supplementary Table 1 from ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical Cancer
ανά: Qin-Shu Li (16990832)
Έκδοση: (2025)

Supplementary Table 2 from ESRRB Inhibits the TGFβ Signaling Pathway to Drive Cell Proliferation in Cervical Cancer
ανά: Qin-Shu Li (16990832)
Έκδοση: (2025)

Supplementary Table 1 from Monounsaturated and Diunsaturated Fatty Acids Sensitize Cervical Cancer to Radiation Therapy
ανά: Naoshad Muhammad (14960127)
Έκδοση: (2025)

Cannot write session to /tmp/vufind_sessions/sess_28agpauiljuljgcclukqnnbulp